De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial

Daniel Ma, Katharine A. Price, Eric J. Moore, Samir H. Patel, Michael L. Hinni, David M. Routman, Briant Fruth, Nathan R. Foster, Kathryn M. Van Abel, Linda X. Yin, M.A. Neben-Wittich, Yolanda I. Garces, L.A. McGee, Scott C. Lester, Jean‐Claude M. Rwigema, Adam L. Holtzman, Daniel L. Price, Jeffrey R. Janus, Jan L. Kasperbauer, Ashish V. Chintakuntlawar, Joaquin Garcia, Robert L. Foote